|
AAK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86517468137026E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.58442181386454E-14 |
| Normal-vs-Stage2 |
3.95670052277808E-10 |
| Normal-vs-Stage3 |
1.62581059726108E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.414380E-01 |
| Stage1-vs-Stage3 |
6.008200E-02 |
| Stage1-vs-Stage4 |
9.62679999999549E-05 |
| Stage2-vs-Stage3 |
1.548050E-02 |
| Stage2-vs-Stage4 |
3.834100E-04 |
| Stage3-vs-Stage4 |
5.749900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63269398001376E-12 |
| Normal-vs-AfricanAmerican |
1.55659929390595E-11 |
| Normal-vs-Asian |
1.6251444634463E-12 |
| Caucasian-vs-AfricanAmerican |
6.448400E-01 |
| Caucasian-vs-Asian |
1.668190E-01 |
| AfricanAmerican-vs-Asian |
1.637360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64979141459298E-12 |
| Normal-vs-Female |
1.64435132177232E-12 |
| Male-vs-Female |
9.702200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63757896132211E-12 |
| Normal-vs-Age(41-60Yrs) |
1.64934732538313E-12 |
| Normal-vs-Age(61-80Yrs) |
6.32827124036339E-14 |
| Normal-vs-Age(81-100Yrs) |
1.169130E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.714200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.904200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.939000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.894000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.368400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.947800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.50371999999566E-05 |
| Classical-VS-Follicular |
1.629640E-04 |
| Classical-VS-Other |
4.696300E-03 |
| Classical-VS-Normal |
1.66533453693773E-14 |
| Tall-VS-Follicular |
1.80600001620235E-09 |
| Tall-VS-Other |
8.532000E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.83740000009914E-07 |
| Follicular-VS-Normal |
5.31619970267627E-10 |
| Other-VS-Normal |
1.11022302462516E-15 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.53796983429311E-13 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.756710E-04 |
|
|
